Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-01-17 @ 9:40 PM
Study NCT ID:
NCT01359657
Status:
COMPLETED
Last Update Posted:
2016-03-16
First Post:
2011-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Sponsor:
Bristol-Myers Squibb
Organization: